Literature DB >> 23111701

Statement of clarification.

.   

Abstract

Entities:  

Year:  2012        PMID: 23111701      PMCID: PMC3505568          DOI: 10.1007/s13244-012-0198-4

Source DB:  PubMed          Journal:  Insights Imaging        ISSN: 1869-4101


× No keyword cloud information.
Since its publication by the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM), the Multimodality Imaging Training Curriculum has given rise to numerous discussions regarding its aims and applicability [1-4]. Both societies therefore wish to clarify specifically the purpose and scope of the document. The aim of the Multimodality Imaging Training Curriculum as a joint European initiative is to advance the quality of performance and reporting of hybrid imaging by defining the scope of training for medical specialists in hybrid imaging. It outlines skills and knowledge requirements in nuclear medicine for those whose training background is in radiology and in radiology for those whose training background is in nuclear medicine. This training curriculum is intended to relate solely to the training of specialists in hybrid imaging from both radiology and nuclear medicine with the purpose of ensuring optimal use of this complex methodology for patient care. It by no means encompasses full training and/or qualification in imaging modalities unrelated to hybrid imaging techniques.
  4 in total

1.  Multimodality imaging training curriculum--parts II and III.

Authors: 
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04       Impact factor: 9.236

2.  Multimodality imaging training curriculum - general recommendations.

Authors: 
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05       Impact factor: 9.236

3.  Multimodality imaging training curriculum-general recommendations.

Authors: 
Journal:  Insights Imaging       Date:  2011-02-11

4.  Multimodality Imaging Training Curriculum - Parts II and III.

Authors: 
Journal:  Insights Imaging       Date:  2012-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.